US Foods

Synlogic Announces Data Presentations at the 2022 Genetic Metabolic Dieticians International (GMDI) Conference and Garrod Symposium

Retrieved on: 
Thursday, April 28, 2022

These include two poster presentations at the Genetic Metabolic Dieticians International (GMDI) Conference being held May 5-7, 2022 in Lake Las Vegas, NV, and a data presentation at the Garrod Symposium being held May 12-14, 2022 in Calgary, Alberta, Canada.

Key Points: 
  • These include two poster presentations at the Genetic Metabolic Dieticians International (GMDI) Conference being held May 5-7, 2022 in Lake Las Vegas, NV, and a data presentation at the Garrod Symposium being held May 12-14, 2022 in Calgary, Alberta, Canada.
  • Genetic Metabolic Dieticians International (GMDI) Conference:
    Title: Dietary Management Outcomes During Synpheny-1, a Phase 2 Clinical Trial of a Live Biotherapeutic, SYNB1618, for the Management of Phenylketonuria
    Date and time: May 5, 2022 from 5:307:00 P.M.
  • The presentations will be available in their respective sections of the Presentations and Publications page on the Synlogic website on the day of the presentations.
  • These forward-looking statements should not be relied upon as representingSynlogic'sview as of any date subsequent to the date hereof.

EMPIRICAL SPINE SUBMITS PMA MODULE II FOR LIMIFLEX™ AS A NEW MOTION-PRESERVING, MINIMALLY INVASIVE STANDARD IN SPINE SURGERY

Retrieved on: 
Wednesday, April 27, 2022

This creates elastic resistance to flexion and maintains lordosis, giving patients the stabilization their spines need while preserving normal motion.

Key Points: 
  • This creates elastic resistance to flexion and maintains lordosis, giving patients the stabilization their spines need while preserving normal motion.
  • Results to date, including this 10-year experience, show the potential for LimiFlex to provide a robust, motion-preserving, minimally invasive, outpatient solution.
  • The company is currently running a pivotal IDE trial in the US on its breakthrough LimiFlex Dynamic Sagittal Tether.
  • LimiFlex is a minimally invasive implant designed to stabilize the spine after open decompression, while preserving motion.

Alation Research Reveals Pending Crisis for Companies – Major Gap Between C-Suite Promises to Invest in Data and Analytics and Actual Funding

Retrieved on: 
Wednesday, April 27, 2022

Theres a lack of funding dedicated to creating a data culture that drives revenue and operational efficiency, said Satyen Sangani, co-founder and CEO, Alation.

Key Points: 
  • Theres a lack of funding dedicated to creating a data culture that drives revenue and operational efficiency, said Satyen Sangani, co-founder and CEO, Alation.
  • For more information, download the Q1 2022 Alation State of Data Culture Report and read the blog, The Data Culture Gap : Q1 2022 State of Data Culture Report.
  • The Alation State of Data Culture Report is a study sponsored by Alation and executed by Wakefield Research.
  • Alation is the leader in enterprise data intelligence solutions including data search & discovery, data governance, data stewardship, analytics, and digital transformation.

Alation Research Reveals Pending Crisis for Companies – Major Gap Between C-Suite Promises to Invest in Data and Analytics and Actual Funding

Retrieved on: 
Wednesday, April 27, 2022

Theres a lack of funding dedicated to creating a data culture that drives revenue and operational efficiency, said Satyen Sangani, co-founder and CEO, Alation.

Key Points: 
  • Theres a lack of funding dedicated to creating a data culture that drives revenue and operational efficiency, said Satyen Sangani, co-founder and CEO, Alation.
  • For more information, download the Q1 2022 Alation State of Data Culture Report and read the blog, The Data Culture Gap : Q1 2022 State of Data Culture Report.
  • The Alation State of Data Culture Report is a study sponsored by Alation and executed by Wakefield Research.
  • Alation is the leader in enterprise data intelligence solutions including data search & discovery, data governance, data stewardship, analytics, and digital transformation.

Hinge Health Launches a Nationally Accessible Women’s Pelvic Health Program

Retrieved on: 
Wednesday, April 27, 2022

Hinge Health , the worlds #1 Digital Musculoskeletal Clinic, announces the launch of a Womens Pelvic Health program , setting a new standard for nationally accessible and clinically validated pelvic healthcare.

Key Points: 
  • Hinge Health , the worlds #1 Digital Musculoskeletal Clinic, announces the launch of a Womens Pelvic Health program , setting a new standard for nationally accessible and clinically validated pelvic healthcare.
  • View the full release here: https://www.businesswire.com/news/home/20220426006354/en/
    Exercise therapy through Women's Pelvic Health from Hinge Health (Photo: Business Wire)
    One in four women has a pelvic floor disorder.
  • The Hinge Health Womens Pelvic Health program member experience includes:
    Care for the unique musculoskeletal needs of women: including prolapse, abdominal separation (diastasis recti), bladder and bowel problems, and chronic pelvic pain.
  • The Womens Pelvic Health program will be available to all customers of Hinge Health, currently totaling 15 million lives across 700 employers and health plans, creating the worlds largest community with access to digital pelvic care.

US Foods Files Investor Presentation Highlighting Track Record of Profitable Growth, Clear Plan to Create Shareholder Value and Highly Qualified and Refreshed Board

Retrieved on: 
Wednesday, April 27, 2022

Highlights of the presentation include:

Key Points: 
  • Highlights of the presentation include:
    US Foods has a track record of profitable growth and is executing on its strategy to drive its balanced long-range plan.
  • US Foods has a compelling plan to drive profitable growth and increase shareholder value.
  • US Foods Board consists of highly qualified directors who are best suited to lead the Company through the successful execution of its strategy.
  • The Board is active, engaged and capable of leading change, with a strong track record of shareholder engagement.

Carrum Health Launches CarrumComplete, Delivering the Industry's Most Complete and Accessible COE Program to Employers

Retrieved on: 
Tuesday, April 26, 2022

SAN FRANCISCO, April 26, 2022 /PRNewswire/ -- Carrum Health today launched CarrumComplete™, its new complete surgical care platform to give employers the industry's first single stop for surgical care. The new offering is powered by CarrumLOCAL™, which matches employer populations with the highest quality surgeons from both the Carrum Health Centers of Excellence (COE) Network and, where a COE may not be generally available, local options within the employer's health plan.

Key Points: 
  • Once they have a provider, they are inundated with the complexities of actually scheduling and preparing for the surgery," said Sach Jain, CEO and founder of Carrum Health.
  • The technology uses the recently announced Carrum Health Quality Algorithm to analyze and identify the top performing providers nationwide.
  • COE Network and Platform Connects members to the industry's leading COE providers in their region and across the nation available on Carrum Health's platform.
  • Existing and new Carrum Health customers will be able to deploy the new platform as an extension of their current solution.

Synlogic Announces Data Presentations from Five Programs at the 2022 Synthetic Biology: Engineering, Evolution & Design (SEED) Conference

Retrieved on: 
Tuesday, April 26, 2022

The poster presentations highlight preclinical and clinical data across five different Synlogic programs.

Key Points: 
  • The poster presentations highlight preclinical and clinical data across five different Synlogic programs.
  • The presentations will be available in their respective sections of the Presentations and Publications page on the Synlogic website on the day of the presentations.
  • Data from a proof-of-concept study assessing the lowering of urinary oxalate in patients who have undergone Roux-en-Y gastric bypass surgery is expected in 2022.
  • These forward-looking statements should not be relied upon as representingSynlogic'sview as of any date subsequent to the date hereof.

DGAP-News: Temedica wins further renowned industry representatives for expert advisory board

Retrieved on: 
Tuesday, April 26, 2022

Dr. Rainer Hess, Prof. Dr. Norbert Klusen and Rudi Lamprecht will continue to serve on the expert advisory board ( https://temedica.com/en/about-us/#experts ).

Key Points: 
  • Dr. Rainer Hess, Prof. Dr. Norbert Klusen and Rudi Lamprecht will continue to serve on the expert advisory board ( https://temedica.com/en/about-us/#experts ).
  • Gloria Seibert, Founder & Chief Executive Officer at Temedica, said:
    "We are proud to win further internationally renowned personalities for our expert advisory board.
  • With Dr. Seimetz, Dr. Oschmann, and Prof. Dr. Dr. Schneeweiss, we expand our advisory board with high-caliber and broad expertise.
  • I am delighted to join Temedica as part of their expert advisory board and to help harness the enormous potential of real-world evidence for the entire industry."

INmune Bio, Inc. to Participate at the B. Riley Neuro & Ophthalmology Conference

Retrieved on: 
Monday, April 25, 2022

The conference is by invitation-only with attendance reserved for B. Riley Securities' institutional clients.

Key Points: 
  • The conference is by invitation-only with attendance reserved for B. Riley Securities' institutional clients.
  • Interested attendees should contact their B. Riley Securities representative to inquire about an invitation.
  • is a publicly traded (NASDAQ: INMB), clinical-stage biotechnology company focused on developing treatments that target the innate immune system to fight disease.
  • Any forward-looking statements contained herein are based on current expectations but are subject to a number of risks and uncertainties.